Group - Botulinum toxin

 


     Related Videos
Poor Nutrition Hormones Infections Toxin Trauma Energy Exercise and Stress - Robert DeJong...
Poor Nutrition Hormones Infections Toxin Trauma Energy Exercise and Stress - Robert DeJong...

     Related Stages/ Members

     Related Hubpages




    Report Abuse    Group Type: wiki group   Moderator:

    Status:  public   Videos: ( 0 )   Documents: ( 0 )  Comments: ( 0 )


    Group-Members ( 0 )    




         Group description

    Botulinum toxin is a medication and a neurotoxic protein produced by the bacterium Clostridium botulinum, and is held to be the most toxic substance known to mankind with an LD50 of roughly 0.005-0.05 µg/kg. Despite its greatest known toxic effect, it is also used in very small doses to treat muscle spasms[citation needed]. Between 1817 and 1822, the German physician and poet Justinus Kerner described botulinum toxin as a "sausage poison" and "fatty poison", , as this bacterium often caused poisoning by growing in improperly handled or prepared meat products. It was Kerner who first conceived a possible therapeutic use of botulinum toxin. In 1870, MĂĽller, another German physician, coined the name botulism, from Latin botulus = "sausage". In 1897, Emile van Ermengem identified the bacterium Clostridium botulinum to be the producer of botulinum toxin. In 1928 Snipe and Hermann Sommer for the first time purified the toxin. In 1949, Burgen's group discovered that botulinium toxin blocks neuromuscular transmission. In the late 1960s Allan Scott and Edward Schantz were the first to work on a standardized botulinum toxin preparation for therapeutic purposes. Other bacteria that produce botulinum toxin are Clostridium butyricum, C.baratii and C.argentinense.  



         Group Videos

    No videos have been added jet. You may join this group and add yours now.


         Group Documents

    No documents have been added jet. You may join this group and add yours now.


         Ongoing discussion



         Related Documents

           Related Groups

             Related Science News

               More on Sciencestage

                 Answers

                 News
            • Neurons from stem cells could replace mice in botulinum test
              (PhysOrg.com) -- Using lab-grown human neurons, researchers from the University of Wisconsin-Madison have devised an effective assay for detecting botulinum neurotoxin, the agent widely used to cosmetically smooth the wrinkles of age and, increasingly, for an array of medical disorders ranging from muscle spasticity to loss of bladder control.
            • Dr. Rhoda S. Narins, New York Dermatological Surgeon, Now Offering the Newest Wrinkle Enhancement and Facial Filler ...
              Dr. Rhoda Narins, a pioneer in bringing liposuction to the United States, and medical expert in all dermal fillers and botulinum injectables available in the U.S., is proud to announce that she now offers the newest innovative anti-aging procedures: LAVIV™ for improvement in the appearance of smile lines, XEOMIN® for improved frown lines, and Belotero® for restoring facial volume.New York, NY ...
            • Dr. Angela Bowers-Plott of Southlake Dermatology Completes Workshop for Safe Facial Injections
              Full face surgical anatomy and injection course designed to improve the safety of botulinum neurotoxin and dermal filler injection procedures(PRWEB) February 07, 2012 As one of the top providers of cosmetic injectable fillers in Tarrant County, Southlake Dermatology is known for providing safe, non invasive treatment of fine lines and wrinkles through the administration of products such as Botox ...
            • Ask Dr. K: Is Botox best for wrinkles?
              Dear Dr. K: I'd like to do something about my wrinkles. Is Botox a good choice? Dear Reader: Botox is a brand name for botulinum toxin type A. This treatment for wrinkles and frown lines has gained quite a following since it was introduced in the late 1980s.
            • Press Release
              GlobalData estimates that the global dystonia therapeutics market was valued at $606m in 2010 and is expected to grow to $1.02 billion with a projected Compound Annual Growth Rate (CAGR) of 6.7%. Such steady growth in the dystonia therapeutics market is primarily attributed to an increase in the prescription population for botulinum toxin (Botox).
            • New anti-wrinkle product competes with Botox
              It's the number one cosmetic procedure in the country: Botox to lift the eyebrows, get rid of wrinkles in the forehead and frown lines between the eyes. More than five million procedures are done yearly because it works. But now Botox Cosmetic has competition.   Board certified dermatologic surgeon Dr. William Coleman, III in Metairie was among the first to test a new product called Xeomin. Like ...
            • The Changing Face of Beauty
              PARIS, January 27, 2012 /PRNewswire/ - 80% of European women believe that aesthetic beauty treatments are acceptable investments IMCAS Merz Aesthetics today releases further intriguing insights uncovered by its ´Face Value´ Beauty Report. …
            • Dr. K: Be realistic about what Botox can fix
              Q I'd like to do something about my wrinkles. Is Botox a good choice?
            • North American Facial Injectable Market to Grow to More Than $1.4 Billion by 2016
              According to Millennium Research Group , the global authority on medical technology market intelligence, the North American facial injectables market will see strong growth through 2016, despite significant downward pressure on selling prices caused by the entry of new, lower-priced products into the market.
            • Research and Markets: Dystonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
              Research and Markets has announced the addition of GlobalData 's new report "Dystonia Therapeutics - Pipeline

                 Related on Wikipedia




























               

              Powered free by PHPmotion